H.Res. 280 · 117th Congress

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.

Stage
In committee
Introduced
2021-03-26
Latest action
2021-03-29 · Referred to the Subcommittee on Health.

Votes

No linked votes are available for this bill.